Change
-2°
Mentions
151
Last Scored
1h ago
Novo Nordisk Nears EU Nod For Oral Wegovy And Investor Opportunity
Assessing Novo Nordisk (CPSE:NOVO B) Valuation After EU Boost For Wegovy Oral Pill
The Next Frontier For GLP-1 Medications: Potential Therapy For Inflammation
Oral Wegovy And Cancer Signals Reframe Novo Nordisk GLP 1 Opportunity
Nina Niu Sanford: ASCO26 Highlights Growing Evidence Around GLP-1 Agonists and Cancer Outcomes
No prediction market data available for this topic
Loading…